Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | ADH1B | P00325 | 1/20 | 0.36 |
| ▸ | ADH1C | P00326 | 1/20 | 0.36 |
| ▸ | ADH1A | P07327 | 1/20 | 0.36 |
| ▸ | ADH4 | P08319 | 1/20 | 0.36 |
| ▸ | ADH7 | P40394 | 1/20 | 0.36 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.36 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL475827 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL3217101 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL489783 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL923748 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL139792 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL924077 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL3092841 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL923753 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL5088250 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| SCHEMBL8383457 | 0.98 | OPRM1 (0.48) | OPRM1SPHK1DNM1LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260110979-A1 | PROCESS CARTRIDGE AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KK (JP) | 2026-04-23 | — | — | US | disclosed |
| US-12509632-B2 | Treatment liquid for semiconductors and method for producing same | TOKUYAMA CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| US-20250261553-A1 | NOVEL COMPOUND, CONJUGATED POLYMER AND METHOD FOR PRODUCING SAME, FILM FORMATION COMPOSITION, ORGANIC THIN FILM AND ORGANIC SEMICONDUCTOR ELEMENT | TOSOH CORPORATION (JP) | 2025-08-14 | — | — | US | disclosed |
| US-12247299-B2 | Treatment liquid for semiconductor with ruthenium and method of producing the same | TOKUYAMA CORPORATION (JP) | 2025-03-11 | — | — | US | disclosed |
| EP-4516794-A1 | NOVEL COMPOUND, CONJUGATED POLYMER AND METHOD FOR PRODUCING SAME, FILM FORMATION COMPOSITION, ORGANIC THIN FILM, AND ORGANIC SEMICONDUCTOR ELEMENT | Tosoh Corporation (JP) | 2025-03-05 | — | — | EP | disclosed |
| CN-119421934-A | Inorganic microparticle dispersion | 住友化学株式会社 | 2025-02-11 | — | — | CN | disclosed |
| US-20240192100-A1 | METHOD FOR TREATING BIOLOGICAL SAMPLE | FUJIREBIO INC. (JP) | 2024-06-13 | — | — | US | disclosed |
| WO-2024111308-A1 | COMPOSITION CONTAINING FLUOROIODOALKANE | 東ソー株式会社 | 2024-05-30 | — | — | WO | disclosed |
| WO-2024071177-A1 | INORGANIC FINE PARTICLE DISPERSION | 住友化学株式会社 | 2024-04-04 | — | — | WO | disclosed |
| EP-4317451-A1 | METHOD FOR TREATING BIOLOGICAL SAMPLE | Fujirebio Inc. (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-20210388508-A1 | TREATMENT LIQUID FOR SEMICONDUCTOR WITH RUTHENIUM AND METHOD OF PRODUCING THE SAME | TOKUYAMA CORPORATION (JP) | 2021-12-16 | — | — | US | disclosed |
| US-10794809-B2 | Method for urine sample analysis, reagent for urine sample analysis, and reagent kit for urine sample analysis | SYSMEX CORPORATION (JP) | 2020-10-06 | — | — | US | disclosed |
| CN-111448161-A | Halogenated heteroalkenyl and heteroalkyl functionalized organic compounds and methods of making these compounds | 阿科玛股份有限公司 | 2020-07-24 | — | — | CN | disclosed |
| EP-3112863-B1 | METHOD FOR DETECTING CASTS AND ERYTHROCYTES IN URINE SAMPLES | SYSMEX CORP (JP) | 2019-07-17 | — | — | EP | disclosed |
| US-9708723-B2 | Electroplating cell, and metal coating and method of forming the same | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2017-07-18 | — | — | US | disclosed |
| EP-3112863-A1 | METHOD FOR URINE SAMPLE ANALYSIS, REAGENT FOR URINE SAMPLE ANALYSIS, AND REAGENT KIT FOR URINE SAMPLE ANALYSIS | Sysmex Corporation (JP) | 2017-01-04 | — | — | EP | disclosed |
| US-20160363521-A1 | METHOD FOR URINE SAMPLE ANALYSIS, REAGENT FOR URINE SAMPLE ANALYSIS, AND REAGENT KIT FOR URINE SAMPLE ANALYSIS | SYSMEX CORPORATION (JP) | 2016-12-15 | — | — | US | disclosed |
| EP-2905361-A1 | ELECTROPLATING CELL, METAL COATING AND METHOD OF FORMING THE SAME | Toyota Jidosha Kabushiki Kaisha (JP) | 2015-08-12 | — | — | EP | disclosed |
| US-20150218723-A1 | ELECTROPLATING CELL, AND METAL COATING AND METHOD OF FORMING THE SAME | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2015-08-06 | — | — | US | disclosed |
| US-20080214386-A1 | Stability; easily separated from solution; surface treatment of catalyst with Group seven compound; reacting epoxide with carbon dioxide | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2008-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260110979-A1 | PROCESS CARTRIDGE AND ELECTROPHOTOGRAPHIC APPARATUS | POT1, TERB1, PSMA4 | OPRM1 3753/4885SPHK1 4681/4885DNM1 2148/4885 |
| US-12509632-B2 | Treatment liquid for semiconductors and method for producing same | GRIN2D, WIZ, EED | OPRM1 2934/4885SPHK1 729/4885DNM1 4624/4885 |
| US-20250261553-A1 | NOVEL COMPOUND, CONJUGATED POLYMER AND METHOD FOR PRODUCING SAME, FILM FORMATION COMPOSITION, ORGANIC THIN FILM AND ORGANIC SEMICONDUCTOR ELEMENT | CD99, SOAT2, SOAT1 | OPRM1 2599/4885SPHK1 3430/4885DNM1 2884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.